-
Bristol Myers Squibb regains exclusive development and commercialization rights for RayzeBio pipeline products in the Greater China market
On December 19th, Bristol Myers Squibb announced that the company has reached an agreement with AbbVie Pharmaceuticals to regain exclusive rights to develop and commercialize ABZ-706 (equivalent to R ...